Cholesterol Testing Market Analysis 2016-2018: Global Strategic Business Forecast to 2024

Thursday, 05. July 2018 10:41

Dublin, July 05, 2018 (GLOBE NEWSWIRE) -- The "Cholesterol Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for Cholesterol Screening and Lab Testing Services for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Cholesterol Testing in US$ Thousand.

The report profiles 29 companies including many key and niche players such as:

  • Abbott Laboratories (USA)
  • AccuTech, LLC (USA)
  • Akers Biosciences, Inc. (USA)
  • Alere Inc. (USA)
  • Beckman Coulter, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Eurofins Scientific (Luxembourg)
  • Boston Heart Diagnostics Corporation (USA)
  • Home Access Health Corporation (USA)
  • Laboratory Corporation of America Holdings (USA)
  • PRIMA Lab SA (Switzerland)
  • PTS Diagnostics (USA)
  • Quest Diagnostics, Inc. (USA)
  • Randox Laboratories Ltd. (UK)
  • Roche Diagnostics (USA)
  • Sekisui Diagnostics, LLC (USA)
  • Siemens Healthineers (Germany)
  • Sigma-Aldrich Corp. (USA)

Key Topics Covered

1. INDUSTRY OVERVIEW
Cholesterol Testing
An Overview
Prevailing Scenario in the Global Healthcare Sector Favors Market Growth
Increasing Healthcare Expenditure
Wider Availability of Healthcare & Diagnostics Services
Growing Health-Consciousness
Lenience Towards Preventive Care
Developed Regions Remain Key Revenue Contributors
Developing Economies Offer Significant Potential
Key Factors Driving Demand for Healthcare Services in Developing Regions
Competitive Scenario
Cholesterol Screening Services
Market Structure
Cholesterol Test Equipment Market
Leading Players
M&A Activity

2. NOTEWORTHY MARKET TRENDS, DRIVERS & CHALLENGES
Growing Prevalence of Cardiovascular Disease Steers Demand for Cholesterol Testing
Global Menace of Cardiovascular Disease: Quick Facts
A Brief Overview of Select Cholesterol-Driven Cardiac Disorders
CVD Statistics
Risk of CVD in Obese People Underpins Cholesterol Testing Volumes
Global Obesity Facts in a Nutshell
Cholesterol Screening Assumes Importance in Diabetes Care
The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening
Aging Population
A Vital Demography
Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects
Healthy Growth in Cardiac IVD Market Augments Market Potential
Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities
POC Diagnostics
An Overview
POC Cholesterol Testing Makes Rapid Gains
Massive Demand for Lipid Panel/Lipid Profile Tests
Northbound Trajectory in POC LPT Services
Rise of C-reactive Protein Tests to Aid Market Growth
Cholesterol Testing: Evolution from Invasive to Non-Invasive
Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain
Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting
Cloud Screening Platforms Extend New Level of Convenience
Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers
A Rapidly Evolving Market Enabled by Technology
Opportunities & Challenges in Self-Testing Industry
E-Retailing Drives Sales of Home Test Kits
A Brief Overview of Select Cholesterol Test Kits

3. CHOLESTEROL TESTING: A BROADER PERSPECTIVE
Blood Cholesterol
The Principal Cardiac Risk Marker
Types of Cholesterol
Total Cholesterol (TC)
High Density Lipoprotein (HDL)
Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL)
Triglycerides (TRG)
Glucose (GLU)
Alanine Aminotransferase (ALT)
Outcomes of High Blood Cholesterol
Atherosclerosis
Coronary Heart Disease (CHD)
Risk Factors and Risk Levels
Risk Factors
Risk Levels
Risk Level Classification under National Heart, Risk Level Based on Total Cholesterol Concentration
Cholesterol Testing & CVD Risk Assessment Techniques
Need for Cholesterol Testing
Candidates for Cholesterol Testing
Test Procedure
Time of Testing
Crucial for Heart Disease Patients
Types of Cholesterol Testing
Cholesterol Screening & Lab Testing Services Providers
Cholesterol Control & Treatment Modalities
Dietary Therapy
Drug Therapy

4. PRODUCT/SERVICE INTRODUCTIONS
Quest Diagnostics Rolls Out Non-Fasting Cholesterol Tests
VAP Diagnostics Lab Relaunches VAP+ Lipid Panel
Bio-Rad Laboratories Unveils Bio-Plex Pro Human Apolipoprotein Panel
Color Genomics Launches New Test for Hereditary High Cholesterol
Admera Health Unveils New DNA Tests
Mayo Clinic Launches Blood Test to Predict Adverse Cardiovascular Events Using Plasma Ceramides
PTS Diagnostics Rolls Out PTS Connect Wellness Solution

5. RECENT INDUSTRY ACTIVITY
Abbott Laboratories to Acquire Alere
Siemens Healthineers to Expand Massachusetts Facility
PTS Bags USFDA Clearance for New Measurement Range for PTS Panels
Alere to Divest Triage Assets to Quidel
Akers Biosciences Inks Distribution Agreement with First Check Diagnostics
Merck to Split into Three Separate Businesses
Atonomics Receives CE Marking for Trace Lipids Test Panel
Siemens Healthineers Partners with DiA Holding
PTS Diagnostics Inks Distribution Agreement with Anda
PTS Diagnostics Renews Multi-Year Agreement with Life Line Screening
Siemens Healthcare Rebrands itself as Siemens Healthineers
Sinocare Acquires PTS Diagnostics
Eurofins Snaps Up Boston Heart Diagnostics
Merck Acquires Sigma-Aldrich
Optum Snaps Up Alere Health from Alere
PTS Diagnostics Collaborates with Blinded Diagnostics

6. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Laboratories (USA)
AccuTech, LLC (USA)
Akers Biosciences, Inc. (USA)
Alere Inc. (USA)
Beckman Coulter, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Eurofins Scientific (Luxembourg)
Boston Heart Diagnostics Corporation (USA)
Home Access Health Corporation (USA)
Laboratory Corporation of America Holdings (USA)
PRIMA Lab SA (Switzerland)
PTS Diagnostics (USA)
Quest Diagnostics, Inc. (USA)
Randox Laboratories Ltd. (UK)
Roche Diagnostics (USA)
Sekisui Diagnostics, LLC (USA)
Siemens Healthineers (Germany)
Sigma-Aldrich Corp. (USA)

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 29

  • The United States (23)
  • Canada (1)
  • Japan (1)
  • Europe (2)
    • Germany (1)
    • The United Kingdom (1)
  • Asia-Pacific (Excluding Japan) (2)

For more information about this report visit https://www.researchandmarkets.com/research/tc3z2z/cholesterol?w=12



CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Cholesterol Testing

Primary Logo

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.